{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:14:50Z","timestamp":1778998490576,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.contraception.2024.110469","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T15:29:28Z","timestamp":1713367768000},"page":"110469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["An assessment of clinical outcomes of medication abortion without pretreatment ultrasonography in Planned Parenthood, United States, 2020\u20132021"],"prefix":"10.1016","volume":"136","author":[{"given":"Hannah R.","family":"Simons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Diemert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Passman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.contraception.2024.110469_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.contraception.2014.01.016","article-title":"Medical management of first-trimester abortion","volume":"89","author":"Bartz","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2024.110469_bib2","unstructured":"National Abortion Federation. Clinical Policy Guidelines for Abortion Care \u00a9\u00a02018.\u00a0https:\/\/5aa1b2xfmfh2e2mk03kk8rsx-wpengine.netdna-ssl.com\/wp-content\/uploads\/2018_CPGs.pdf\u00a0(accessed October 26, 2019)."},{"key":"10.1016\/j.contraception.2024.110469_bib3","unstructured":"U.S. Food & Drug Administration. Mifeprex (mifepristone) information. https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/mifeprex-mifepristone-information\u00a0(accessed October 26, 2019)."},{"key":"10.1016\/j.contraception.2024.110469_bib4","unstructured":"Food and Drug Administration. MIFEPREX (mifepristone) tablets label. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/020687s020lbl.pdf\u00a0(accessed October 26, 2019)."},{"key":"10.1016\/j.contraception.2024.110469_bib5","unstructured":"Planned Parenthood Federation of America. Medical standards and guidelines; 2022."},{"issue":"4","key":"10.1016\/j.contraception.2024.110469_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.contraception.2006.11.011","article-title":"Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research","volume":"75","author":"Clark","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2024.110469_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.contraception.2015.04.008","article-title":"Early medical abortion without prior ultrasound","volume":"92","author":"Raymond","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2024.110469_bib8","unstructured":"Centers for Disease Control and Prevention. Current trends ectopic pregnancy -- United States, 1990\u20131992.\u00a0https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00035709.htm\u00a0(accessed October 26, 2019)."},{"issue":"5","key":"10.1016\/j.contraception.2024.110469_bib9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0002-9378(97)70410-1","article-title":"New technologies permit safe abortion at less than six weeks' gestation and provide timely detection of ectopic gestation","volume":"176","author":"Edwards","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.contraception.2024.110469_bib10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/AOG.0000000000004756","article-title":"Mifepristone and misoprostol for pregnancies of unknown location","volume":"139","author":"Goldberg","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.contraception.2024.110469_bib11","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/1471-0528.16668","article-title":"Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study","volume":"128","author":"Aiken","year":"2021","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.contraception.2024.110469_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/AOG.0000000000005016","article-title":"No test medication abortion: a systematic review","volume":"141","author":"Pearlman-Shapiro","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.contraception.2024.110469_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.contraception.2017.11.005","article-title":"Simplified medical abortion screening: a demonstration project","volume":"97","author":"Raymond","year":"2018","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2024.110469_bib14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.contraception.2021.07.108","article-title":"Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S.","volume":"104","author":"Anger","year":"2021","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2024.110469_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamainternmed.2022.0217","article-title":"Outcomes and safety of history-based screening for medication abortion: a retrospective multicenter cohort study","volume":"182","author":"Upadhyay","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.contraception.2024.110469_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.contraception.2021.03.025","article-title":"Provision of medication abortion in Hawai'i during COVID-19: practical experience with multiple care delivery models","volume":"104","author":"Kerestes","year":"2022","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2024.110469_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1363\/psrh.12215","article-title":"Abortion incidence and service availability in the United States, 2020","volume":"54","author":"Jones","year":"2022","journal-title":"Perspect Sex Reprod Health"},{"issue":"9","key":"10.1016\/j.contraception.2024.110469_bib18","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/1471-0528.15684","article-title":"Telemedicine for medical abortion: a systematic review","volume":"126","author":"Endler","year":"2019","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.contraception.2024.110469_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/AOG.0000000000000897","article-title":"Mifepristone with buccal misoprostol for medical abortion: a systematic review","volume":"126","author":"Chen","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2024.110469_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.109996","article-title":"An examination of loss to follow-up and potential bias in outcome ascertainment in a study of direct-to-patient telemedicine abortion in the United States","volume":"122","author":"Rosenberg","year":"2023","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782424001410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782424001410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T02:27:01Z","timestamp":1728008821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782424001410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":20,"alternative-id":["S0010782424001410"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110469","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An assessment of clinical outcomes of medication abortion without pretreatment ultrasonography in Planned Parenthood, United States, 2020\u20132021","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110469"}}